Products are for professional/laboratory use only
Explore Recent Scientific Contributions Using Invivoscribe’s Products
Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.
Key opinion leaders across the world have recently published papers that discuss the advantages of using highly sensitive next-generation sequencing (NGS) for Minimal Residual Disease (MRD) testing.
Key Topics Discussed:
- MRD testing for Multiple Myeloma, CLL & AML with NGS
- Transitioning from Capillary Electrophoresis to NGS
- Advantages of using NGS versus Flow Cytometry
|
LymphoTrack Assays |
|
| B-cell | IGHV Leader SHM |
| IGH FR1/2/3 Combo | |
| IGH FR1 | |
| IGH FR2 | |
| IGH FR3 | |
| T-cell | TRG |
| TRB |
